Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer

Imaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.

Bibliographic Details
Main Authors: Naoki Nishio, Nynke S. van den Berg, Stan van Keulen, Brock A. Martin, Shayan Fakurnejad, Nutte Teraphongphom, Stefania U. Chirita, Nicholas J. Oberhelman, Guolan Lu, Crista E. Horton, Michael J. Kaplan, Vasu Divi, A. Dimitrios Colevas, Eben L. Rosenthal
Format: Article
Language:English
Published: Nature Portfolio 2019-11-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-019-13076-7
_version_ 1818433239540301824
author Naoki Nishio
Nynke S. van den Berg
Stan van Keulen
Brock A. Martin
Shayan Fakurnejad
Nutte Teraphongphom
Stefania U. Chirita
Nicholas J. Oberhelman
Guolan Lu
Crista E. Horton
Michael J. Kaplan
Vasu Divi
A. Dimitrios Colevas
Eben L. Rosenthal
author_facet Naoki Nishio
Nynke S. van den Berg
Stan van Keulen
Brock A. Martin
Shayan Fakurnejad
Nutte Teraphongphom
Stefania U. Chirita
Nicholas J. Oberhelman
Guolan Lu
Crista E. Horton
Michael J. Kaplan
Vasu Divi
A. Dimitrios Colevas
Eben L. Rosenthal
author_sort Naoki Nishio
collection DOAJ
description Imaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.
first_indexed 2024-12-14T16:17:56Z
format Article
id doaj.art-9d94d112023644caad227f072f22a399
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-14T16:17:56Z
publishDate 2019-11-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-9d94d112023644caad227f072f22a3992022-12-21T22:54:52ZengNature PortfolioNature Communications2041-17232019-11-0110111010.1038/s41467-019-13076-7Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancerNaoki Nishio0Nynke S. van den Berg1Stan van Keulen2Brock A. Martin3Shayan Fakurnejad4Nutte Teraphongphom5Stefania U. Chirita6Nicholas J. Oberhelman7Guolan Lu8Crista E. Horton9Michael J. Kaplan10Vasu Divi11A. Dimitrios Colevas12Eben L. Rosenthal13Department of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Pathology, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineDepartment of Medicine, Division of Medical Oncology, Stanford University School of MedicineDepartment of Otolaryngology-Head and Neck Surgery, Stanford University School of MedicineImaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.https://doi.org/10.1038/s41467-019-13076-7
spellingShingle Naoki Nishio
Nynke S. van den Berg
Stan van Keulen
Brock A. Martin
Shayan Fakurnejad
Nutte Teraphongphom
Stefania U. Chirita
Nicholas J. Oberhelman
Guolan Lu
Crista E. Horton
Michael J. Kaplan
Vasu Divi
A. Dimitrios Colevas
Eben L. Rosenthal
Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
Nature Communications
title Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_full Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_fullStr Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_full_unstemmed Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_short Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
title_sort optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer
url https://doi.org/10.1038/s41467-019-13076-7
work_keys_str_mv AT naokinishio opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT nynkesvandenberg opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT stanvankeulen opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT brockamartin opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT shayanfakurnejad opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT nutteteraphongphom opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT stefaniauchirita opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT nicholasjoberhelman opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT guolanlu opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT cristaehorton opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT michaeljkaplan opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT vasudivi opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT adimitrioscolevas opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer
AT ebenlrosenthal opticalmolecularimagingcandifferentiatemetastaticfrombenignlymphnodesinheadandneckcancer